Bladder Cancer Survival in Men Using 5-Alpha-Reductase Inhibitors

March 2018 in “ European Urology Supplements ”

Ville Mäkelä, Andres Kotsar, Teuvo L.J. Tammela, Teemu J. Murtola

5-alpha-reductase inhibitors 5-ARIs androgen-related cancer progression

TLDR Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

The study examined the effects of 5-alpha-reductase inhibitors (5-ARIs) on bladder cancer survival in 10,720 Finnish men diagnosed between 1997 and 2012. It found that pre-diagnostic and post-diagnostic use of 5-ARIs was associated with a reduced risk of bladder cancer-specific death, with hazard ratios of 0.84 and 0.77, respectively. The risk reduction was more pronounced with longer use. In contrast, alpha-blockers did not significantly affect bladder cancer survival. The findings suggested that 5-ARIs could improve bladder cancer outcomes by potentially influencing androgen-related cancer progression.

View this study on trepo.tuni.fi →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Testosterone and hair loss seeming irrelevance

in Research/Science 79 upvotes 1 year ago

The conversation is about the role of testosterone in hair loss and the effectiveness of different treatments. The conclusion is that DHT is the main culprit for hair loss, and finasteride has been proven to work long-term in maintaining and regrowing hair. Testosterone may have a minor effect, but it is not the primary cause of hair loss.

community The truth about Dutasteride (w/ sources)

in Finasteride/Dutasteride 52 upvotes 2 years ago

The effectiveness of Dutasteride compared to Finasteride in treating hair loss, with evidence given such as studies and experiences, as well as discussion around whether one should switch from Finasteride to Dutasteride. There is also a discussion on post-Dutasteride syndrome.

community The Real Cause Of Androgenetic Alopecia

in Research/Science 673 upvotes 4 months ago

Androgenetic alopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.

community If you're sitting there wondering, "I'm losing my hair, what do I do?" then read my advice here. I've been fighting the fight for 7 years, with great success. (pictures included)

in Question 109 upvotes 11 years ago

Fighting hair loss with "The Big 3" treatments of Propecia, Rogaine and Nizoral shampoo, as well as specific advice on how to use these products. People have shared their long-term success stories and some have discussed the side effects of finasteride. Other suggestions included Lipogaine and Pura D'or Hair Loss Prevention Therapy Shampoo & Conditioner.

community Having androgen receptor density and sensitivity at wrong f*ing place

in Satire 7 upvotes 4 months ago

The conversation discusses hair loss treatments, focusing on the use of topical minoxidil, microneedling, finasteride, and dutasteride, while debating the role of testosterone and DHT in hair loss. It also touches on the potential liver health impacts of these treatments and the genetic sensitivity of hair follicles to androgens.

community Everyone is ignoring that plasma finasteride levels are 100x lower with topical compared to oral.

in Research/Science 137 upvotes 7 months ago

Topical finasteride results in plasma levels 100 times lower than oral finasteride, potentially reducing systemic side effects. Users report similar efficacy with fewer side effects, suggesting a preference for topical application.

Related Research

2 / 2 results

research The Effects of Oral 5-Alpha Reductase Inhibitors on Penile Intracavernosal Pressures and Penile Morphology in a Rat Model

2 citations, May 2019 in “PubMed”

Oral finasteride and dutasteride may negatively affect erectile function in rats.

research Establishment of Type II 5α-Reductase Over-Expressing Cell Line as an Inhibitor Screening Model

12 citations, June 2007 in “Journal of steroid biochemistry and molecular biology/The Journal of steroid biochemistry and molecular biology”

A reliable model for screening type II 5α-reductase inhibitors was created and validated.